Loading...
NPI 1902008170 · Fort Myers, FL · Clinical Pathology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Wilfredo Blasini is a clinical pathology physician provider located in Fort Myers, Florida. This profile covers 97 Medicare and 33 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Wilfredo Blasini |
| Address | 2848 Center Pointe Dr Ste A |
| City | Fort Myers |
| State | FL |
| ZIP | 33916 |
| Taxonomy | Clinical Pathology Physician |
| NPI Enumerated | June 1, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $16.9M |
| Medicaid | $307.9K |
WILFREDO BLASINI presents as a high-volume clinical pathology/laboratory operator: the top Medicare revenue driver is 81455 ($5M, 32.5% of Medicare revenue), complemented by very large volumes of routine chemistry and immunology panels such as 80053 ($1.8M, 11.5%) and ferritin 82728 ($881.6K, 5.8%). The mix of codes—molecular oncology panel 81455, high counts of routine panels (80053), and specialty protein/immunology testing—indicates a lab that combines both large-scale routine testing and advanced molecular/pathology services rather than a purely outpatient clinical practice.
Revenue concentration is significant on both payers: the top three Medicare codes account for 49.8% of Medicare revenue and the top three Medicaid codes account for 49.4% of Medicaid revenue. For Medicare those top three are led by 81455 ($5M, 32.5%), 80053 ($1.8M, 11.5%), and 82728 ($881.6K, 5.8%); for Medicaid the top three are 80053 ($85.1K, 26.9%), 86300 ($38.4K, 12.1%), and 82378 ($32.9K, 10.4%), so shifts in ordering or reimbursement for a small set of codes would materially affect revenue.
The payer mix is heavily Medicare-skewed: total Medicare revenue is $16.9M versus total Medicaid revenue of $307.9K, showing Medicare is the dominant revenue source rather than a balanced dual-payer book. Medicaid appears to be a minor adjunct to the provider’s operations in dollar terms, while Medicare volume drives scale and market standing.
National competitive standing on many Medicare codes is well above typical: the provider ranks as an extreme outlier on several routine and specialty tests (for example 80053 ranks #29 of 26416, 100th percentile, labeled “extreme outlier”; 82728 ranks #7 of 8797, 100th percentile, “extreme outlier”), and is the national leader on selected codes (82378 ranks #1 of 1557, 100th percentile). These rankings suggest the entity functions as a major national-volume source for both routine analytes and select tumor markers rather than a modest local lab.
Medicaid competitive standing is more modest in-state: common Medicaid codes show typical to above-typical volumes without clear dominance—80053 ranks #169 of 642 in-state (74th percentile, labeled “typical, unremarkable”), 86300 ranks #6 of 27, and 82378 ranks #10 of 57 (84th percentile). In short, the provider’s Medicaid footprint is meaningful for certain tests but lacks the statewide dominance this entity demonstrates nationally on Medicare for many assays.
Specialized pathology and molecular services form a visible revenue layer beyond routine chemistry: codes tied to specialized diagnostics carry substantial Medicare revenue—88374 ($503.5K, 3.3%), 88237 ($452.2K, 3.0%), 88185 ($506.4K, 3.3%)—and those codes generally rank in the upper national percentiles (88374 #10 of 378, 98th percentile; 88237 #3 of 107, 98th percentile). This profile points to an operational capability in immunohistochemistry/ISH, cytogenetics, and flow cytometry alongside high-throughput chemistry testing, consistent with a reference-lab model.
Multiple codes are flagged as statistical outliers, which has operational implications: dozens of listed Medicare codes are described as “extreme outlier, far above typical national volume for this code” or “notably above typical national volume,” including 83521, 82784, 82607, 83540, 86334 and others. Those outlier labels imply unusually concentrated ordering patterns or centralized processing capacity, so payer policy changes or network shifts affecting a handful of high-volume codes could disproportionately alter provider revenue.
The provider shows tenure and an established presence: NPI enumerated 2007-06-01 (~19 years ago), indicating a long-running operation. Combined with the high national ranks and concentrated revenue streams, the longevity supports the interpretation of an established lab operator with sustained referral or capture for both routine and specialized diagnostic testing.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
97 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81455 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for DNA and possibly RNA alterations in 51 or more genes known to… | 1,750 | $2,850 | $5M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 175,920 | $10 | $1.8M |
| 82728 | The lab analyst measures the level of ferritin, an important protein composed of about 20 percent iron. Ferritin also acts as an iron reserve in the body, and is present in serum in only minute… | 67,820 | $10 | $881.6K |
| 83521 | The lab analyst performs a chemistry test to measure the level of each immunoglobulin light chain, kappa or lambda, in a serum specimen. A common lab method for this test is turbidimetry, which uses… | 42,110 | $20 | $715.9K |
| 82784 | The lab analyst performs the technical lab test to analyze the concentration of a particular gamma globulin in the specimen. The analyst may test for immunoglobulin A, immunoglobulin D,… | 63,300 | $10 | $569.7K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 36,510 | $20 | $547.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 26,650 | $20 | $506.4K |
| 88374 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. The lab analyst processes the slides… | 2,100 | $240 | $503.5K |
| 88237 | The lab analyst performs a procedure to grow a culture of cells from bone marrow or blood in a neoplastic disorder. | 3,210 | $140 | $452.2K |
| 82378 | The lab analyst performs the technical lab test to analyze the quantity of carcinoembryonic antigen, or CEA, in the blood or other bodily fluid. Most commonly clinicians order a CEA test to monitor… | 23,160 | $20 | $440.1K |
Showing 1–10 of 97
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 97 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
97 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81455 | 2 | 10 | 80 | $2,860 | $2M |
| 88374 | 5 | 30 | 130 | $160 | $278.1K |
| 88185 | 2 | 20 | 4,720 | $20 | $222.5K |
| 88237 | 2 | 10 | 140 | $140 | $175.8K |
| 83521 | 1 | 10 | 3,990 | $20 | $163.5K |
| 81339 | 19 | 30 | 110 | $180 | $116.4K |
| 81279 | 22 | 30 | 140 | $180 | $106.7K |
| 88264 | 2 | 10 | 440 | $140 | $96.7K |
| 81206 | 9 | 10 | 110 | $160 | $87.7K |
| 88305 | 280 | 980 | 570 | $40 | $83.5K |
Showing 1–10 of 97
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
33 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 17,020 | $10 | $85.1K |
| 86300 | The lab analyst performs a quantitative test to evaluate the patient’s serum for the cancer tumor antigen CA 15 3, a tumor marker for breast cancer, and a similar marker called CA 27.29. | 3,200 | $10 | $38.4K |
| 82378 | The lab analyst performs the technical lab test to analyze the quantity of carcinoembryonic antigen, or CEA, in the blood or other bodily fluid. Most commonly clinicians order a CEA test to monitor… | 3,290 | $10 | $32.9K |
| 82728 | The lab analyst measures the level of ferritin, an important protein composed of about 20 percent iron. Ferritin also acts as an iron reserve in the body, and is present in serum in only minute… | 5,990 | $1 | $23.9K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 3,440 | $10 | $20.6K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 2,530 | $10 | $17.7K |
| 84466 | The lab analyst performs a test to measure the amount of transferrin in patient blood. | 1,950 | $10 | $11.7K |
| 83550 | The lab analyst measures the iron binding capacity, typically in a serum sample. This analyte is an important measurement of the capacity of iron to bind to transferrin. That capacity is also known… | 3,790 | $1 | $11.4K |
| 83540 | The lab analyst measures the iron level, primarily in serum. Iron is one of the essential elements in the body, and the greatest portion is present combined with hemoglobin within the red blood cells. | 5,680 | $1 | $11.4K |
| 82746 | The lab analyst measures the folic acid level in serum to determine if there is a deficiency. Folic acid deficiency is attributed to many conditions such as malabsorption, Crohn’s disease, celiac… | 2,180 | $10 | $10.9K |
Showing 1–10 of 33
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
33 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 169 | 640 | 4,400 | $10 | $193.4K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 46 | 70 | 180 | $20 | $178K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 25 | 30 | 590 | $70 | $119.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 439 | 820 | 1,430 | $1 | $92.8K |
| 83540 | The lab analyst measures the iron level, primarily in serum. Iron is one of the essential elements in the body, and the greatest portion is present combined with hemoglobin within the red blood cells. | 29 | 620 | 690 | $30 | $82.3K |
| 83550 | The lab analyst measures the iron binding capacity, typically in a serum sample. This analyte is an important measurement of the capacity of iron to bind to transferrin. That capacity is also known… | 30 | 550 | 590 | $30 | $79K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 113 | 340 | 220 | $10 | $67.4K |
| 82728 | The lab analyst measures the level of ferritin, an important protein composed of about 20 percent iron. Ferritin also acts as an iron reserve in the body, and is present in serum in only minute… | 33 | 630 | 500 | $20 | $64.5K |
| 87340 | The lab analyst performs a test to detect hepatitis B surface antigen, also called HBsAg, using an immunoassay technique, such as EIA. | 189 | 350 | 320 | $20 | $48.1K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 135 | 480 | 1,100 | $1 | $42K |
Showing 1–10 of 33
Other providers in the same ZIP code as Wilfredo Blasini, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.